What is the recommended dosage of omeprazole (Oneptazole) for a 6-month-old pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Omeprazole Dosing for 6-Month-Old Pediatric Patient

For a 6-month-old infant with severe or refractory GERD, start omeprazole at 0.7 mg/kg/day divided into two doses, which can be escalated up to 1.4-2.8 mg/kg/day in divided doses based on clinical response. 1

Weight-Based Dosing Algorithm

  • Initial dose: 0.7 mg/kg/day divided into 2 doses (e.g., for a 7 kg infant: approximately 2.5 mg twice daily) 1, 2
  • Dose escalation: If inadequate response after 14 days, increase in increments of 0.7 mg/kg/day 2
  • Maximum dose: Up to 2.8 mg/kg/day may be required in refractory cases 1, 2

The majority of infants under 2 years respond to the initial 0.7 mg/kg/day dosage, though approximately 40% may require higher doses up to 1.4 mg/kg/day, and occasionally up to 2.8 mg/kg/day for adequate acid suppression 2.

Preparation and Administration

Since no commercial pediatric formulation exists for this age group, prepare a compounded suspension:

  • Use omeprazole capsules mixed with applesauce for immediate administration, OR 1
  • Have a retail pharmacy compound a 6 mg/mL suspension 1
  • For a typical 7 kg infant at 0.7 mg/kg/day (approximately 5 mg/day): Administer 0.83 mL of 6 mg/mL suspension divided into two doses (approximately 0.4 mL twice daily) 1

The compounded suspension maintains stability and allows accurate dosing for small infants who cannot swallow capsules 1.

Clinical Monitoring

  • Assess response at 14 days: If symptoms persist or pH monitoring shows inadequate acid suppression, escalate the dose 2
  • Monitor for adverse effects: Headaches, diarrhea, and nausea are most common, though generally well-tolerated in this age group 1
  • Long-term considerations: For therapy exceeding 2.5 years, monitor for enterochromaffin cell hyperplasia, though this is rarely relevant for initial treatment courses 1

Critical Dosing Considerations

Common pitfall: Underdosing is frequent in infants under 2 years because providers often use the older pediatric dosing (10-20 mg once daily for children ≥2 years), which is inadequate for this age group 1. Infants require weight-based dosing starting at 0.7 mg/kg/day, not fixed-dose regimens 1, 2.

Pharmacokinetic differences: Infants have prolonged elimination half-lives (55-90 hours vs. 30 hours in adults) and altered volumes of distribution, necessitating the weight-based approach rather than extrapolating adult doses 3, 4.

Dose titration is essential: Unlike older children where fixed doses are standard, infants frequently require individualized dose escalation based on clinical response and pH monitoring when available 2. Approximately 50% of infants need doses higher than the initial 0.7 mg/kg/day to achieve adequate acid control 2.

References

Guideline

Pediatric Omeprazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dosing considerations in the pediatric patient.

Clinical therapeutics, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.